110 related articles for article (PubMed ID: 36453694)
1. Impact of Time From Diagnosis to Treatment Start on the Outcomes of Patients With Nonmetastatic Anal Squamous Cell Carcinoma.
Abdel-Rahman O; Ghosh S
Am J Clin Oncol; 2023 Jan; 46(1):31-35. PubMed ID: 36453694
[TBL] [Abstract][Full Text] [Related]
2. Patterns of Care and Comparison of Outcomes Between Primary Anal Squamous Cell Carcinoma and Anal Adenocarcinoma.
Malakhov N; Kavi AM; Lee A; Adedoyin P; Sheth N; Lederman AJ; Schreiber D
Dis Colon Rectum; 2019 Dec; 62(12):1448-1457. PubMed ID: 31725581
[TBL] [Abstract][Full Text] [Related]
3. Comparative Survival of Patients With Anal Adenocarcinoma, Squamous Cell Carcinoma of the Anus, and Rectal Adenocarcinoma.
Franklin RA; Giri S; Valasareddy P; Lands LT; Martin MG
Clin Colorectal Cancer; 2016 Mar; 15(1):47-53. PubMed ID: 26362848
[TBL] [Abstract][Full Text] [Related]
4. Race- and Sex-Based Disparities in the Therapy and Outcomes of Squamous Cell Carcinoma of the Anus.
Arora N; Gupta A; Zhu H; Christie A; Meyer JJ; Khan SA; Beg MS
J Natl Compr Canc Netw; 2017 Aug; 15(8):998-1004. PubMed ID: 28784861
[No Abstract] [Full Text] [Related]
5. Racial disparities in receipt of standard chemoradiation in anal squamous cell carcinoma, an analysis of the National Cancer Database.
Bian SX; Chen DH; Lin E
Cancer Med; 2021 Jan; 10(2):575-585. PubMed ID: 33305908
[TBL] [Abstract][Full Text] [Related]
6. Anal cancer survival: a socioeconomic analysis.
Ali F; Ghareeb AE; Jha A; Van der Voet H; Garg D; Jha M
Ann R Coll Surg Engl; 2021 Mar; 103(3):191-196. PubMed ID: 33645271
[TBL] [Abstract][Full Text] [Related]
7. Does race impact survival for patients with anal squamous cell carcinoma?
Fields AC; Welten VM; Lu P; Goldberg JE; Irani J; Bleday R; Melnitchouk N
J Surg Oncol; 2019 Dec; 120(7):1201-1207. PubMed ID: 31549446
[TBL] [Abstract][Full Text] [Related]
8. The impact of gender and HPV status on anal squamous cell carcinoma survival.
Baidoun F; Saad AM; Abdel-Rahman O
Int J Colorectal Dis; 2021 Oct; 36(10):2093-2109. PubMed ID: 33787999
[TBL] [Abstract][Full Text] [Related]
9. A Population-Based Cohort Analysis of Chemoradiation Versus Radiation Alone for Definitive Treatment of Stage I Anal Cancer in Older Patients.
Buckstein M; Arens Y; Wisnivesky J; Gaisa M; Goldstone S; Sigel K
Dis Colon Rectum; 2018 Jul; 61(7):787-794. PubMed ID: 29771796
[TBL] [Abstract][Full Text] [Related]
10. Racial and economic disparities in the treatment of penile squamous cell carcinoma: Results from the National Cancer Database.
Sharma P; Ashouri K; Zargar-Shoshtari K; Luchey AM; Spiess PE
Urol Oncol; 2016 Mar; 34(3):122.e9-15. PubMed ID: 26547834
[TBL] [Abstract][Full Text] [Related]
11. Impact of socioeconomic status on survival for patients with anal cancer.
Lin D; Gold HT; Schreiber D; Leichman LP; Sherman SE; Becker DJ
Cancer; 2018 Apr; 124(8):1791-1797. PubMed ID: 29527660
[TBL] [Abstract][Full Text] [Related]
12. Conditional Survival in Anal Carcinoma Using the National Population-Based Survey of Epidemiology and End Results Database (1988-2012).
Kim E; Kim JS; Choi M; Thomas CR
Dis Colon Rectum; 2016 Apr; 59(4):291-8. PubMed ID: 26953987
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus.
Toh E; Wilson J; Sebag-Montefiore D; Botterill I
Colorectal Dis; 2014 Mar; 16(3):O90-7. PubMed ID: 24148256
[TBL] [Abstract][Full Text] [Related]
14. Anal Squamous Cell Carcinoma: Radiation Therapy Alone Must Be Avoided.
Almaazmi H; Taylor JP; Stem M; Yu D; Lo BD; Safar B; Efron JE
J Surg Res; 2020 Mar; 247():530-540. PubMed ID: 31648811
[TBL] [Abstract][Full Text] [Related]
15. Racial Disparities in Time to Treatment Initiation and Outcomes for Early Stage Anal Squamous Cell Carcinoma.
Goksu SY; Ozer M; Kazmi SMA; Aguilera TA; Ahn C; Hsiehchen D; Sanjeevaiah A; Maxwell MC; Beg MS; Sanford NN
Am J Clin Oncol; 2020 Nov; 43(11):762-769. PubMed ID: 32804778
[TBL] [Abstract][Full Text] [Related]
16. Optimal Radiotherapy Dose in Anal Cancer: Trends in Prescription Dose and Association with Survival.
Shah NK; Qureshi MM; Dyer MA; Truong MT; Mak KS
J Gastrointest Cancer; 2021 Mar; 52(1):229-236. PubMed ID: 32152823
[TBL] [Abstract][Full Text] [Related]
17. Impact of cytoreductive surgery on outcomes of metastatic appendiceal carcinoma: a real-world, population-based study.
Abdel-Rahman O
J Comp Eff Res; 2020 Apr; 9(6):431-439. PubMed ID: 32253936
[No Abstract] [Full Text] [Related]
18. Association of Treatment Inequity and Ancestry With Pancreatic Ductal Adenocarcinoma Survival.
Heller DR; Nicolson NG; Ahuja N; Khan S; Kunstman JW
JAMA Surg; 2020 Feb; 155(2):e195047. PubMed ID: 31800002
[TBL] [Abstract][Full Text] [Related]
19. The effect of dose escalation for large squamous cell carcinomas of the anal canal.
Prasad RN; Elson J; Kharofa J
Clin Transl Oncol; 2018 Oct; 20(10):1314-1320. PubMed ID: 29623585
[TBL] [Abstract][Full Text] [Related]
20. Survival Outcomes and Patterns of Management for Anal Adenocarcinoma.
Lewis GD; Haque W; Butler EB; Teh BS
Ann Surg Oncol; 2019 May; 26(5):1351-1357. PubMed ID: 30719638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]